-- 
Sanofi-Aventis Shareholders Approve Name Change to ‘Sanofi’

-- B y   A l b e r t i n a   T o r s o l i
-- 
2011-05-06T16:09:13Z

-- http://www.bloomberg.com/news/2011-05-06/sanofi-aventis-shareholders-approve-name-change-to-sanofi-.html
Sanofi-Aventis SA (SAN)  shareholders
approved a proposal by the board to simplify the French
pharmaceutical company’s name to “Sanofi.”  The new name will be simpler and easier to pronounce in
some countries, Chief Executive Officer Chris Viehbacher said at
the annual shareholder meeting in Paris today. The change will
take effect today, the company said.  Sanofi, the maker of treatments such as Lovenox blood
thinner and Lantus diabetes medicine, took its current form in
2004 following drug-industry consolidations dating back more
than a decade. The Aventis portion of the name emerged from the
1999 combination of Frankfurt-based Hoechst AG and Paris-based
Rhone-Poulenc SA of  France . Sanofi-Synthelabo SA acquired the
merged German-French company seven years ago.  The board decided on the change in part because a six-
syllable name is difficult to pronounce in some countries, such
as  China , Jean-Marc Podvin, a spokesman for Paris-based Sanofi,
said on April 1.  Sanofi, France’s largest drugmaker, is seeking to expand in
emerging markets such as China and India. The company  To contact the reporter on this story:
Albertina Torsoli in Paris at 
 atorsoli@bloomberg.net   To contact the editor responsible for this story:
Phil Serafino at 
 pserafino@bloomberg.net  